E-LIB Suche - Ergebnisse für: Minato, Koichi

1

A phase II study of atezolizumab with bevacizumab, carbopla..:

Watanabe, Satoshi ; Furuya, Naoki ; Nakamura, Atsushi...
European Journal of Cancer. 197 (2024) - p. 113469 , 2024

Link: https://doi.org/10.1016/..

2

A phase 2 trial of durvalumab treatment following radiation..:

Yamada, Tadaaki ; Goto, Yasuhiro ; Tanaka, Hiroshi...
European Journal of Cancer. 195 (2023) - p. 113373 , 2023

Link: https://doi.org/10.1016/..

3

Ramucirumab Plus Docetaxel for Patients with Non-small cell..:

Tanimura, Keiko ; Uchino, Junji ; Kimura, Hideharu...
The Oncologist. 28 (2023) 6 - p. 551-e454 , 2023

Link: https://doi.org/10.1093/..

4

Comparative analysis of different response criteria at earl..:

Kaira, Kyoichi ; Yamaguchi, Ou ; Naruse, Ichiro...
Cancer Imaging. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

A randomized phase III study of docetaxel alone versus doce..:

Atagi, Shinji ; Daimon, Takashi ; Okishio, Kyoichi...
Thoracic Cancer. 14 (2023) 29 - p. 2941-2949 , 2023

Link: https://doi.org/10.1111/..

6

A Retrospective Study of the Efficacy and Safety of Naldeme..:

Kamiya, Teruhiko ; Imai, Hisao ; Fujita, Yukiyoshi...
Medicina. 59 (2023) 3 - p. 492 , 2023

Link: https://doi.org/10.3390/..

7

Pretreatment glasgow prognostic score predicts survival amo..:

Wasamoto, Satoshi ; Imai, Hisao ; Tsuda, Takeshi...
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Predictive significance of circulating tumor DNA against pa..:

Yamaguchi, Ou ; Kasahara, Norimitsu ; Soda, Hiroshi...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

Real‐world data of atezolizumab plus carboplatin and etopos..:

Shiono, Ayako ; Imai, Hisao ; Wasamoto, Satoshi...
Cancer Medicine. 12 (2022) 1 - p. 73-83 , 2022

Link: https://doi.org/10.1002/..

10

Efficacy and safety of amrubicin monotherapy after atezoliz..:

Imai, Hisao ; Nagai, Yoshiaki ; Minemura, Hiroyuki...
Investigational New Drugs. 40 (2022) 5 - p. 1066-1079 , 2022

Link: https://doi.org/10.1007/..

11

A retrospective study of the efficacy and safety of naldeme..:

Imai, Hisao ; Fujita, Yukiyoshi ; Hiruta, Eriko...
Thoracic Cancer. 13 (2022) 16 - p. 2301-2308 , 2022

Link: https://doi.org/10.1111/..

12

A Phase II Trial on Osimertinib as a First-Line Treatment f..:

Chihara, Yusuke ; Takeda, Takayuki ; Goto, Yasuhiro...
The Oncologist. 27 (2022) 11 - p. 903-e834 , 2022

Link: https://doi.org/10.1093/..

13

Post‐progression survival after atezolizumab plus carboplat..:

Masubuchi, Ken ; Imai, Hisao ; Wasamoto, Satoshi...
Thoracic Cancer. 13 (2022) 19 - p. 2776-2785 , 2022

Link: https://doi.org/10.1111/..

14

First-line nivolumab plus ipilimumab combined with two cycl..:

John, Thomas ; Sakai, Hiroshi ; Ikeda, Satoshi...
International Journal of Clinical Oncology. 27 (2022) 4 - p. 695-706 , 2022

Link: https://doi.org/10.1007/..

15

Efficacy and Safety of Naldemedine for Patients with Cancer..:

Nishiba, Hiromi ; Imai, Hisao ; Fujita, Yukiyoshi...
Journal of Clinical Medicine. 11 (2022) 9 - p. 2672 , 2022

Link: https://doi.org/10.3390/..